Bruce W. Penman

4.7k citations

38 papers · 3.9k indexed · 2 hit papers · h-index 25

Molecular Biology top 5%
Health, Toxicology and Mutagenesis top 1%
Cancer Research top 2%
Pharmacology top 0.2%
Oncology top 5%

Co-authors: Charles L. Crespi William F. Busby Arthur L. Lafleur John L. Durant William G. Thilly J S Wishnok Steven R. Tannenbaum Tam T. Nguyen
Topics: Carcinogens and Genotoxicity Assessment (16 papers)DNA Repair Mechanisms (12 papers)Pharmacogenetics and Drug Metabolism (12 papers)
Cited by: Pharmacology Health, Toxicology and Mutagenesis Cancer Research
Journals: Proceedings of the National Academy of Sciences Environmental Science & Technology JNCI Journal of the National Cancer Institute
Partner nations: United States Israel

In The Last Decade

Bruce W. Penman

38 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA damage and mutation in human cells exposed to nitric oxide in vitro.

1992 806 citations Charles L. Crespi, Bruce W. Penman et al. profile →
Human cell mutagenicity of oxygenated, nitrated and unsubstituted polycyclic aromatic hydrocarbons associated with urban aerosols

1996 713 citations John L. Durant, William F. Busby et al. Mutation Research/Genetic Toxicology profile →

Peers

Countries citing papers authored by Bruce W. Penman

Since Specialization

Citations

This map shows the geographic impact of Bruce W. Penman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce W. Penman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce W. Penman more than expected).

Fields of papers citing papers by Bruce W. Penman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce W. Penman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce W. Penman. The network helps show where Bruce W. Penman may publish in the future.

Co-authorship network of co-authors of Bruce W. Penman

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce W. Penman. A scholar is included among the top collaborators of Bruce W. Penman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce W. Penman. Bruce W. Penman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human-Cell Mutagens in Respirable Airborne Particles in the Northeastern United States. 1. Mutagenicity of Fractionated Samples 2003 ·Environmental Science & Technology ·D. Pedersen,John L. Durant,Bruce W. Penman,Charles L. Crespi,Harold F. Hemond,Arthur L. Lafleur,Glen R. Cass	66
2	Human cell mutagenicity of chlorinated and unchlorinated water and the disinfection byproduct 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) 2001 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·(unknown),John L. Durant,(unknown),Charles L. Crespi,Bruce W. Penman	20
3	Mutagenicity of C24H14 PAH in human cells expressing CYP1A1 1999 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·John L. Durant,Arthur L. Lafleur,William F. Busby,(unknown),Bruce W. Penman,Charles L. Crespi	96
4	Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. 1999 ·Pharmaceutical Research ·Ming Hu,Yiqi Li,Christine M. Davitt,Shiew‐Mei Huang,Kenneth E. Thummel,Bruce W. Penman,Charles L. Crespi	47
5	Bioassay-Directed Chemical Analysis of Los Angeles Airborne Particulate Matter Using a Human Cell Mutagenicity Assay 1998 ·Environmental Science & Technology ·Michael Hannigan,Glen R. Cass,Bruce W. Penman,Charles L. Crespi,Arthur L. Lafleur,William F. Busby,William G. Thilly,Bernd R.T. Simoneit	125
6	Use of cDNA-Expressed Human Cytochrome P450 Enzymes to Study Potential Drug-Drug Interactions 1997 ·Advances in pharmacology ·Charles L. Crespi,Bruce W. Penman	101
7	Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. 1997 ·PubMed ·Erin Code,Charles L. Crespi,Bruce W. Penman,Frank J. Gonzalez,Thomas K. H. Chang,David J. Waxman	212
8	Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450 1997 ·Analytical Biochemistry ·Charles L. Crespi,Vaughn P. Miller,Bruce W. Penman	345
9	Mutagenicity of the atmospheric transformation products 2-nitrofluoranthene and 2-nitrodibenzopyranone in Salmonella and human cell forward mutation assays 1997 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·William F. Busby,(unknown),Charles L. Crespi,Bruce W. Penman,Arthur L. Lafleur	9
10	Human cell mutagenicity of oxygenated, nitrated and unsubstituted polycyclic aromatic hydrocarbons associated with urban aerosolsbreakdown → 1996 ·Mutation Research/Genetic Toxicology ·John L. Durant,William F. Busby,Arthur L. Lafleur,Bruce W. Penman,Charles L. Crespi	713
11	Mutagenicity of benzo[a]pyrene and dibenzopyrenes in the Salmonella typhimurium TM677 and the MCL-5 human cell forward mutation assays 1995 ·Mutation Research/Genetic Toxicology ·William F. Busby,(unknown),Charles L. Crespi,Bruce W. Penman	67
12	Human cell mutagenicity of mono- and dinitropyrenes in metabolically competent MCL-5 cells 1994 ·Mutation Research/Genetic Toxicology ·William F. Busby,Bruce W. Penman,Charles L. Crespi	39
13	Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6 1993 ·Pharmacogenetics ·Bruce W. Penman,Jeffrey M. Reece,Theresa J. Smith,Chunsong Yang,H V Gelboin,Frank J. Gonzalez,Charles L. Crespi	50
14	The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B₁ and comparison to CYP1A2 and CYP2A3 1991 ·Carcinogenesis ·Charles L. Crespi,Bruce W. Penman,Dorothy T. Steimel,Harry V. Gelboin,Frank J. Gonzalez	107
15	Sodium fluoride is a less efficient human cell mutagen at low concentrations 1990 ·Environmental and Molecular Mutagenesis ·Charles L. Crespi,(unknown),Thomas R. Turner,Bruce W. Penman	21
16	The mutagenic activity of selected compounds at the TK locus: Rodent vs. human cells 1988 ·Mutation Research/Reviews in Genetic Toxicology ·William J. Caspary,Robert Langenbach,Bruce W. Penman,Charles L. Crespi,B. Myhr,Ann D. Mitchell	24
17	Analysis of human lymphoblast mutation assays by using historical negative control data bases 1987 ·Environmental and Molecular Mutagenesis ·Bruce W. Penman,Charles L. Crespi	27
18	Perylene is a more potent mutagen than benzo[α]pyrene for S. typhimurium 1980 ·Mutation Research/Genetic Toxicology ·Bruce W. Penman,Debra A. Kaden,Howard L. Liber,Thomas R. Skopek,William G. Thilly,Ronald A. Hites	6
19	Concentration-Dependent Mutation by Alkylating Agents in Human Lymphoblasts and <italic>Salmonella typhimurium: N</italic>-Methyl-<italic>N</italic>-nitrosourethane and β-Propiolactone<xref ref-type="fn" rid="FN2">2</xref> 1979 ·JNCI Journal of the National Cancer Institute ·Bruce W. Penman,Heinrich C. Hoppe,William G. Thilly	7
20	Phenotypic lag and mutation to 6-thioguanine resistance in diploid human lymphoblasts 1978 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·William G. Thilly,John G. DeLuca,H. Hoppe,Bruce W. Penman	59

About Bruce W. Penman

Bruce W. Penman is a scholar working on Pharmacology, Cancer Research and Pharmaceutical Science, having authored 38 papers that have together received 3.9k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (16 papers), DNA Repair Mechanisms (12 papers) and Pharmacogenetics and Drug Metabolism (12 papers). The work is most often cited by research in Pharmacology (816 citations), Health, Toxicology and Mutagenesis (1.0k citations) and Cancer Research (848 citations). Bruce W. Penman has collaborated with scholars based in United States and Israel. Frequent co-authors include Charles L. Crespi, William F. Busby, Arthur L. Lafleur, John L. Durant, William G. Thilly, J S Wishnok, Steven R. Tannenbaum, Tam T. Nguyen, Vaughn P. Miller and Howard L. Liber. Their work appears in journals such as Proceedings of the National Academy of Sciences, Environmental Science & Technology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact